Pediatrix Medical Group, Inc.
MDPediatrix Medical Group, Inc. (MD) is a healthcare company specializing in neonatal and pediatric subspecialty care. Founded in 1996, it provides both hospital-based and office-based services, including neonatal fetal and maternal care, pediatric cardiology, and other subspecialties. The company partners with hospitals and healthcare providers to deliver high-quality medical services for infants and children.
Company News
ARS Pharmaceuticals reported $32.5 million in revenue for Q3 2025, primarily from neffy epinephrine nasal spray sales. The company continues to expand market presence through direct-to-consumer campaigns and has strong cash reserves of $288.2 million.
Pediatrix Medical Group reported strong Q2 2025 earnings, with non-GAAP EPS of $0.53 beating analyst expectations. Despite a 7.4% revenue decline due to practice divestitures, the company showed growth in hospital-based neonatal services and raised its adjusted EBITDA guidance.
Investors need to pay close attention to Pediatrix Medical (MD) stock based on the movements in the options market lately.
In the preceding three months, 4 analysts have released ratings for Pediatrix Medical Group (NYSE:MD), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish So...
